Zimmer Biomet

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products.

CEO

Ivan Tornos

CEOIvan Tornos

Employees

17,000

Employees17,000

Headquarters

Warsaw, Indiana

HeadquartersWarsaw, Indiana

Founded

1927

Founded1927

Employees

17,000

Employees17,000

ZBH Key Statistics

Market cap

15.93B

Market cap15.93B

Price-Earnings ratio

21.38

Price-Earnings ratio21.38

Dividend yield

1.17%

Dividend yield1.17%

Average volume

2.33M

Average volume2.33M

High today

$83.18

High today$83.18

Low today

$81.58

Low today$81.58

Open price

$82.65

Open price$82.65

Volume

3.14M

Volume3.14M

52 Week high

$108.29

52 Week high$108.29

52 Week low

$79.12

52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $82.33, with a market capitalization of 15.93B. The stock trades at a price-to-earnings (P/E) ratio of 21.38 and offers a dividend yield of 1.2%.

On 2026-05-31, Zimmer Biomet(ZBH) stock moved within a range of $81.58 to $83.18. With shares now at $82.33, the stock is trading +0.9% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 3.14M, compared to an average daily volume of 2.33M.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

ZBH News

Simply Wall St 2d

Assessing Zimmer Biomet Valuation After Recent Weak Share Price Momentum

Advertisement Zimmer Biomet’s recent share performance Zimmer Biomet Holdings (ZBH) has drawn investor attention after a mixed stretch, with the stock edging...

TipRanks 3d

Zimmer Biomet price target lowered to $93 from $95 at Citi

Citi lowered the firm’s price target on Zimmer Biomet (ZBH) to $93 from $95 and keeps a Neutral rating on the shares. The firm updated models in the medical tec...

TipRanks 4d

Zimmer Biomet Shareholders Reaffirm Board, Leadership and Oversight

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

66%

of 29 ratings

Buy

31%

Hold

65.5%

Sell

3.4%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.